PCSK9 binds to multiple receptors and can be functionally inhibited by an EGF-A peptide

This publication has 28 references indexed in Scilit:

• Molecular basis for LDL receptor recognition by PCSK9
  Proceedings of the National Academy of Sciences, 2008
• Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activity
  Biochemical Journal, 2007
• The Cellular Trafficking of the Secretory Proprotein Convertase PCSK9 and Its Dependence on the LDLR
  Traffic, 2007
• Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice
  Journal of Clinical Investigation, 2006
• Structure of an LDLR-RAP Complex Reveals a General Mode for Ligand Recognition by Lipoprotein Receptors
  Published by Elsevier ,2006
• Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart Disease
  New England Journal of Medicine, 2006
• What Promise Does PCSK9Hold?
  Journal of the American College of Cardiology, 2005
• Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype
  Proceedings of the National Academy of Sciences, 2004
• Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
  Nature Genetics, 2003
• The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation
  Proceedings of the National Academy of Sciences, 2003